Merriman Curhan Ford initiates coverage on Depomed (Nasdaq: DEPO) with a Buy. Price target range $10-13.

Merriman analyst says, "Depomed ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE